181 related articles for article (PubMed ID: 20431849)
1. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
Zakai NA; Lutsey PL; Folsom AR; Heckbert SR; Cushman M
Thromb Haemost; 2010 Aug; 104(2):207-12. PubMed ID: 20431849
[TBL] [Abstract][Full Text] [Related]
2. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology.
Cushman M; O'Meara ES; Folsom AR; Heckbert SR
Blood; 2009 Oct; 114(14):2878-83. PubMed ID: 19617576
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
[TBL] [Abstract][Full Text] [Related]
4. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.
Lutsey PL; Folsom AR; Heckbert SR; Cushman M
J Thromb Haemost; 2009 Oct; 7(10):1639-48. PubMed ID: 19656279
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism.
Hoke M; Kyrle PA; Minar E; Bialonzcyk C; Hirschl M; Schneider B; Kollars M; Weltermann A; Eichinger S
Thromb Haemost; 2005 Oct; 94(4):787-90. PubMed ID: 16270631
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
Ohira T; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Zakai NA; Rosamond WD; Folsom AR
J Thromb Haemost; 2007 Jul; 5(7):1455-61. PubMed ID: 17425663
[TBL] [Abstract][Full Text] [Related]
7. Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke.
Duering C; Kosch A; Langer C; Thedieck S; Nowak-Göttl U
Thromb Haemost; 2004 Oct; 92(4):707-12. PubMed ID: 15467899
[TBL] [Abstract][Full Text] [Related]
8. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
Cao X; Su Y; Zhang W; Zhao H; Wen M; Lu S; Zhao Y; Chen Y; Liu L; Zang X; Wu J
Clin Appl Thromb Hemost; 2021; 27():10760296211063877. PubMed ID: 34898295
[TBL] [Abstract][Full Text] [Related]
10. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
Dahm A; Van Hylckama Vlieg A; Bendz B; Rosendaal F; Bertina RM; Sandset PM
Blood; 2003 Jun; 101(11):4387-92. PubMed ID: 12560220
[TBL] [Abstract][Full Text] [Related]
11. Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis.
Tardy-Poncet B; Tardy B; Laporte S; Mismetti P; Amiral J; Piot M; Reynaud J; Campos L; Decousus H
J Thromb Haemost; 2003 Mar; 1(3):507-10. PubMed ID: 12871458
[TBL] [Abstract][Full Text] [Related]
12. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
[TBL] [Abstract][Full Text] [Related]
13. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
14. Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.
Fei X; Wang H; Yuan W; Wo M; Jiang L
Biomed Res Int; 2017; 2017():8983763. PubMed ID: 28246607
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
16. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
17. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
18. Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.
Chougule A; Rajpal S; Ahluwalia J; Bose SK; Masih J; Das R; Kumar N; Malhotra P; Suri V
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):58-63. PubMed ID: 26340461
[TBL] [Abstract][Full Text] [Related]
19. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
[TBL] [Abstract][Full Text] [Related]
20. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
Jianlong M; Diansheng Z; Jing R
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
